Literature DB >> 28326830

Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes, Obesity and Lifestyle Study.

Simran Johal1,2, Kris M Jamsen1, J Simon Bell1,3, Kevin P Mc Namara1,4,5, Dianna J Magliano3,6, Danny Liew3, Taliesin E Ryan-Atwood1, Claire Anderson2, Jenni Ilomäki1,3.   

Abstract

Background Lifestyle and dietary advice typically precedes or accompanies the prescription of statin medications. However, evidence for adherence to this advice is sparse. The objective was to compare saturated fat intake, exercise, alcohol consumption and smoking between statin users and non-users in Australia. Methods Data were analysed for 4614 participants aged ≥37 years in the Australian Diabetes, Obesity and Lifestyle study in 2011-2012. Statin use, smoking status and physical activity were self-reported. Saturated fat and alcohol intake were measured via a food frequency questionnaire. Multinomial logistic regression was used to compute adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between statin use and the four lifestyle factors. All models were adjusted for age, sex, education, number of general practitioner visits, body mass index, hypertension, diabetes and prior cardiovascular diseases. Results In total 1108 (24%) participants used a statin. Statin users were 29% less likely to be within the highest quartile versus the lowest quartile of daily saturated fat intake compared to non-users (OR 0.71, 95% CI 0.54-0.94). There were no statistically significant associations between statin use and smoking, physical activity or alcohol consumption. Conclusions Smoking status, alcohol consumption and exercise level did not differ between users and non-users of statins. However, statin users were less likely to consume high levels of saturated fat than non-users. We found no evidence that people took statins to compensate for a poor diet or lifestyle.

Entities:  

Keywords:  HMG-CoA reductase inhibitors; Smoking; alcohol drinking; cohort study; diet; epidemiology; exercise

Mesh:

Substances:

Year:  2016        PMID: 28326830     DOI: 10.1177/2047487316684054

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

1.  Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study.

Authors:  Karen Ho; Kris M Jamsen; J Simon Bell; Maarit Jaana Korhonen; Kevin P Mc Namara; Dianna J Magliano; Danny Liew; Taliesin E Ryan-Atwood; Jonathan E Shaw; Susan Luc; Jenni Ilomäki
Journal:  Eur J Clin Pharmacol       Date:  2018-07-19       Impact factor: 2.953

2.  Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.

Authors:  Ainhoa Oñatibia-Astibia; Amaia Malet-Larrea; Belen Larrañaga; Miguel Ángel Gastelurrutia; Begoña Calvo; Dulce Ramírez; Ignacio Cantero; Ángel Garay; Estibaliz Goyenechea
Journal:  Health Serv Res       Date:  2019-04-07       Impact factor: 3.402

3.  Relationship Between Internet Health Information and Patient Compliance Based on Trust: Empirical Study.

Authors:  Xinyi Lu; Runtong Zhang; Wen Wu; Xiaopu Shang; Manlu Liu
Journal:  J Med Internet Res       Date:  2018-08-17       Impact factor: 5.428

4.  Impact of Physician-Patient Communication in Online Health Communities on Patient Compliance: Cross-Sectional Questionnaire Study.

Authors:  Xinyi Lu; Runtong Zhang
Journal:  J Med Internet Res       Date:  2019-05-13       Impact factor: 5.428

5.  Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression Approach.

Authors:  Adelle M Gadowski; Natalie Nanayakkara; Stephane Heritier; Dianna J Magliano; Jonathan E Shaw; Andrea J Curtis; Sophia Zoungas; Alice J Owen
Journal:  Nutrients       Date:  2019-08-09       Impact factor: 5.717

6.  Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.

Authors:  Maarit J Korhonen; Jaana Pentti; Juha Hartikainen; Jenni Ilomäki; Soko Setoguchi; Danny Liew; Mika Kivimäki; Jussi Vahtera
Journal:  J Am Heart Assoc       Date:  2020-02-05       Impact factor: 5.501

7.  Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study.

Authors:  Rui Valdiviesso; Ana Rita Sousa-Santos; Luís F Azevedo; Emília Moreira; Teresa F Amaral; José Silva-Cardoso; Nuno Borges
Journal:  BMC Cardiovasc Disord       Date:  2022-08-05       Impact factor: 2.174

8.  Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study.

Authors:  Noriko Kameyama; Chizuko Maruyama; Yuri Shijo; Ariko Umezawa; Aisa Sato; Makoto Ayaori; Katsunori Ikewaki; Masako Waki; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2019-10-03       Impact factor: 4.928

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.